Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

A Historical Look at the Characterization of Lupus as a Systemic Disease

Ruth Jessen Hickman, MD  |  Issue: October 2018  |  October 18, 2018

Dr. Kaposi was both Dr. Hebra’s student and his son-in-law. Called by some the “father of German dermatology,” Dr. Kaposi is known for a number of achievements, including his work on Kaposi sarcoma and xeroderma pigmentosum.10 But among Dr. Kaposi’s most important contributions is his characterization of lupus.

In 1869, Dr. Kaposi published his first paper on the topic, in Archiv für Dermatologie und Syphilis. He briefly recounted the history of the term, speculated on etiology and discussed symptomatic treatment.2 In his much more extensive 42-page paper published in 1872, Dr. Kaposi included 11 detailed case studies, with extensive characterizations of symptoms, disease course and microscopy information consolidated from additional patients.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Kaposi could present no explanation of the disease etiology, but considered the disease inflammatory in nature, based on its histopathology. He also noted that “most of the diseased are found in persons of middle age,” and “the female sex will be affected by the disease much more often than the male.” This was the first description of the systemic nature of the disease and its severe constitutional and visceral manifestations.2

For Dr. Kaposi to group together patients with such varied manifestations as arthritis, pleurisy & coma, all of whom also had cutaneous lupus, was bold & prescient.

Commentary

Dr. Salmon

Dr. Salmon

Jane Salmon, MD, is a professor of medicine at the Hospital for Special Surgery and the director of the Lupus and APS Center of Excellence in New York City. “Earlier physicians had done wonderful work and wrote eloquent descriptions distinguishing lupus erythematosus from tuberculosis and other entities,” Dr. Salmon notes. “But it was Dr. Kaposi who identified lupus as a disease of young women that was systemic and life threatening. For this reason, I think this paper is really interesting.”

In his 1872 paper, which summarized and built on previous descriptions, Dr. Kaposi acknowledged others’ contributions to characterizing the disease. He wrote, “As a new experience, it is to be added that: The lupus erythematosus may also appear and progress under the appearance of a widespread or subacute, feverish eruption and then, often affected with severe local and general symptoms of illness of the entire organism which can, indeed, endanger and destroy its life.”

Dr. Salmon notes that at the time, medical scholarship heavily relied on descriptive case series. In his extensive descriptions, Dr. Kaposi said, “Edematosis and thickening, glandular, painful swelling of the skin and tissues around the joints of the middle hand fingers, toes and also of the larger joints of the knee, of the elbow,” and also mentioned “ripping, tearing, deep bone pains, especially in the main bones, especially the tibia, forearm and carpal bones.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 4 5 6 7 | Single Page
Share: 

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:Classification CriteriaDr. Moriz KaposiHistoryLost & Found

Related Articles

    Rheumatologists, Social Workers Collaborate to Help Patients with Lupus

    April 19, 2017

    At the Hospital for Special Surgery (HSS), New York, rheumatologists and social workers have found that an interdisciplinary approach to care for systemic lupus erythematosus (SLE) patients improves the overall patient experience. “Our goal is to help patients navigate the complex healthcare system,” says Jillian Rose, LCSW, MPH, assistant director, Community Engagement, Diversity & Research….

    Lupus often presents with a butterfly rash.

    Top 12: Research in Systemic Lupus Erythematosus at a Glance

    November 18, 2021

    Dr. Pisetsky’s picks for the top research in lupus presented at ACR Convergence 2021.

    T Cells in Systemic Lupus Erythematosus

    August 1, 2011

    Progress toward targeted therapy

    2019 EULAR/ACR SLE Classification Criteria Offer Improved Sensitivity & Specificity

    November 6, 2019

    The new EULAR/ACR classification criteria for SLE offer improved sensitivity and specificity, as well as more accurately reflect the current tests used to clinically diagnose SLE. A positive ANA test is obligatory…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences